TECOGEN INC/WALTHAM MA (TGEN) Stock Fundamental Analysis

NYSEARCA:TGEN • US87876P2011

3.76 USD
+0.08 (+2.17%)
At close: Feb 25, 2026
3.76 USD
0 (0%)
After Hours: 2/25/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TGEN. TGEN was compared to 42 industry peers in the Building Products industry. TGEN has a bad profitability rating. Also its financial health evaluation is rather negative. TGEN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • TGEN had negative earnings in the past year.
  • In the past year TGEN had a positive cash flow from operations.
  • TGEN had negative earnings in 4 of the past 5 years.
  • In multiple years TGEN reported negative operating cash flow during the last 5 years.
TGEN Yearly Net Income VS EBIT VS OCF VS FCFTGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

  • TGEN has a worse Return On Assets (-15.31%) than 83.33% of its industry peers.
  • With a Return On Equity value of -46.53%, TGEN is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROIC N/A
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
TGEN Yearly ROA, ROE, ROICTGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With an excellent Gross Margin value of 43.64%, TGEN belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • TGEN's Gross Margin has improved in the last couple of years.
  • TGEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
TGEN Yearly Profit, Operating, Gross MarginsTGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TGEN has been increased compared to 1 year ago.
  • Compared to 5 years ago, TGEN has more shares outstanding
  • The debt/assets ratio for TGEN is higher compared to a year ago.
TGEN Yearly Shares OutstandingTGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
TGEN Yearly Total Debt VS Total AssetsTGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 1.56, we must say that TGEN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.56, TGEN is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of TGEN is 0.63, which is an excellent value as it means it would take TGEN, only 0.63 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.63, TGEN belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
  • TGEN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of TGEN (0.18) is better than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Altman-Z 1.56
ROIC/WACCN/A
WACC9.01%
TGEN Yearly LT Debt VS Equity VS FCFTGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that TGEN should not have too much problems paying its short term obligations.
  • The Current ratio of TGEN (1.32) is worse than 80.95% of its industry peers.
  • A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
  • The Quick ratio of TGEN (0.74) is worse than 88.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.74
TGEN Yearly Current Assets VS Current LiabilitesTGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for TGEN have decreased strongly by -220.48% in the last year.
  • The Revenue has been growing slightly by 2.46% in the past year.
  • Measured over the past years, TGEN shows a decrease in Revenue. The Revenue has been decreasing by -5.52% on average per year.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%27.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 38.30% on average over the next years. This is a very strong growth
  • TGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.20% yearly.
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TGEN Yearly Revenue VS EstimatesTGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
TGEN Yearly EPS VS EstimatesTGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • TGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TGEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TGEN Price Earnings VS Forward Price EarningsTGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, TGEN is valued a bit more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.31
EV/EBITDA N/A
TGEN Per share dataTGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • A cheap valuation may be justified as TGEN's earnings are expected to decrease with -38.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TGEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TECOGEN INC/WALTHAM MA

NYSEARCA:TGEN (2/25/2026, 8:04:00 PM)

After market: 3.76 0 (0%)

3.76

+0.08 (+2.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-12
Earnings (Next)03-12
Inst Owners29.01%
Inst Owner Change-3.97%
Ins Owners22.95%
Ins Owner Change0%
Market Cap112.24M
Revenue(TTM)25.00M
Net Income(TTM)-4.76M
Analysts82.86
Price Target15.3 (306.91%)
Short Float %8.6%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-52.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.96
P/FCF 36.31
P/OCF 27.64
P/B 10.97
P/tB 20.9
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY2.75%
OCF(TTM)0.14
OCFY3.62%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.64%
FCFM 13.67%
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 175.01%
Cap/Sales 4.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.74
Altman-Z 1.56
F-Score4
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%27.58%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.59%
EBIT Next 3Y70.17%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A

TECOGEN INC/WALTHAM MA / TGEN FAQ

What is the fundamental rating for TGEN stock?

ChartMill assigns a fundamental rating of 2 / 10 to TGEN.


What is the valuation status of TECOGEN INC/WALTHAM MA (TGEN) stock?

ChartMill assigns a valuation rating of 1 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.


What is the profitability of TGEN stock?

TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for TGEN stock?

The Earnings per Share (EPS) of TECOGEN INC/WALTHAM MA (TGEN) is expected to decline by -53% in the next year.